rs13412852 — LPIN1

LPIN1 rs13412852 — The Sedentary Liver Variant

LPIN1 encodes lipin-1, a dual-function protein at the heart of lipid metabolism. In the cytoplasm, lipin-1 acts as a phosphatidic acid phosphohydrolase¹¹ phosphatidic acid phosphohydrolase
A Mg²⁺-dependent enzyme that converts phosphatidic acid to diacylglycerol, the branch-point metabolite required for both triglyceride storage and phospholipid membrane synthesis. In the nucleus, lipin-1 switches roles entirely: it acts as a transcriptional co-activator of PGC-1α and PPARα, driving genes for fatty acid oxidation and mitochondrial metabolism while suppressing lipogenic gene expression. This makes LPIN1 a physiological gatekeeper that normally keeps the liver from accumulating excess fat during periods of caloric load.

The rs13412852 C>T variant sits within an intron of LPIN1 on chromosome 2 (chr2:11,774,815, GRCh38) and does not alter the protein sequence. Its functional impact is not established at the molecular level, but population studies have uncovered context-dependent associations with liver fat, triglycerides, and disease progression — associations that differ strikingly between children and adults.

The Mechanism

LPIN1 is on the plus strand of chromosome 2. The rs13412852 C allele is the GRCh38 reference allele, present on approximately 75% of chromosomes globally. The T allele (minor allele, ~25% globally) may alter intronic regulatory elements — such as splicing enhancers, microRNA binding sites in the pre-mRNA, or chromatin accessibility signals — though no specific molecular mechanism has been established.

The most clinically distinctive feature of this variant is a gene-environment interaction²² gene-environment interaction
A pattern where a genetic variant's effect on disease depends on an environmental exposure; here, physical activity level acts as the environmental modifier. In adults who are physically active, the T allele appears to have a modest or even protective metabolic effect. In adults with sedentary behavior, T-carrier status substantially amplifies the risk of metabolic dysfunction-associated steatotic liver disease (MASLD).

The Evidence

Pediatric NAFLD (protective signal): A study by Valenti et al. 2012³³ Valenti et al. 2012
Valenti L et al. LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2012 examined 142 children with biopsy-proven NAFLD and 337 healthy controls. The TT genotype was under-represented among pediatric NAFLD cases (7% vs 14% in controls; OR 0.58, 95% CI 0.35–0.91). Children with the TT genotype had significantly less severe liver damage (NAFLD activity score, P=0.026) and a lower prevalence of liver fibrosis (P=0.012, adjusted OR 0.29, 95% CI 0.11–0.66). The same group found TT homozygosity associated with lower triglycerides in both patients and healthy controls.

These findings fed into a 4-polymorphism pediatric NASH risk score⁴⁴ 4-polymorphism pediatric NASH risk score
Nobili V et al. 2014 — combining PNPLA3 rs738409, SOD2 rs4880, KLF6 rs3750861, and LPIN1 rs13412852 to predict NASH in obese children; AUC 0.75 for the genetic score, 0.80 for the combined clinical-genetic model.

Adult MASLD (risk signal with sedentary behavior): A 2026 Italian cohort study by Franco et al.⁵⁵ Franco et al.
Franco I et al. The Interplay of Genetics and Lifestyle in MASLD: Focus on LPIN1 rs13412852 and Sedentary Behaviour. Int J Mol Sci. 2026 genotyped 394 adults and found that CT/TT genotype was associated with MASLD independently (OR 1.80, 95% CI 1.06–3.05, P=0.03). Sedentary behavior was also an independent risk factor (OR 1.72, P <0.05). The critical finding was their interaction: individuals with both moderate-to-severe sedentary behavior and the CT/TT genotype had an MASLD risk of OR 2.99 (95% CI 1.39–6.45, P=0.005) — roughly tripling risk compared to physically active CC individuals.

UK meta-analysis (minimal effect on fasting metabolites): A meta-analysis of 8,504 UK subjects found only a nominal association between rs13412852 T allele and lower BMI (P=0.042) and slightly lower fasting insulin, with no significant association with insulin resistance overall. The authors concluded that common LPIN1 variation has no major effect on metabolic traits in isolation.

The evidence level remains emerging: the adult-sedentary interaction is a compelling finding from a single moderate-sized cohort (n=394) requiring replication. The pediatric protection signal, though biologically plausible, also requires larger studies.

Practical Actions

The most actionable implication of rs13412852 is that T-carriers should be particularly vigilant about physical inactivity. The sedentary-genotype interaction suggests that the T allele heightens the liver's vulnerability to the metabolic consequences of reduced physical activity. This is genotype- specific advice: the roughly 3-fold risk amplification in sedentary T-carriers is meaningfully larger than the sedentary risk seen in CC individuals alone.

T-carriers with existing sedentary work or lifestyle patterns should prioritize breaking sitting time with structured movement, and should monitor hepatic fat markers (liver enzymes, hepatic ultrasound) if other risk factors for MASLD are present (obesity, insulin resistance, dyslipidemia).

Interactions

This variant does not have documented gene-gene interactions, but it is part of a validated 4-variant pediatric NASH risk score alongside PNPLA3 rs738409 (I148M), SOD2 rs4880, and KLF6 rs3750861. Individuals who carry the LPIN1 T allele alongside the PNPLA3 GG risk genotype face the highest combined pediatric NASH risk in that score. The relationship between LPIN1 lipin-1 and the PPARG/PGC-1α transcriptional axis also suggests that PPARG variants (such as the Pro12Ala polymorphism) may modulate how strongly LPIN1 expression is regulated — though this gene-gene interaction has not been directly tested for rs13412852.